Together, the results of the Annexin V apoptosis assay, caspase-3/7 activity assay, and immunoblots for cleaved caspase-3 and PARP make it likely that the observed reduction in viability seen in multiple myeloma cells treated with cPLA2α inhibitors is due to induction of apoptosis. This evidence concerns the gene CASP3 and AL amyloidosis.